nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—SLCO2B1—Montelukast—chronic obstructive pulmonary disease	0.329	0.43	CbGbCtD
Fexofenadine—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.106	0.138	CbGbCtD
Fexofenadine—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0998	0.131	CbGbCtD
Fexofenadine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0605	0.0792	CbGbCtD
Fexofenadine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0605	0.0792	CbGbCtD
Fexofenadine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.054	0.0705	CbGbCtD
Fexofenadine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0286	0.0374	CbGbCtD
Fexofenadine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.027	0.0353	CbGbCtD
Fexofenadine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00113	0.00496	CcSEcCtD
Fexofenadine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.00483	CcSEcCtD
Fexofenadine—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00478	CcSEcCtD
Fexofenadine—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00478	CcSEcCtD
Fexofenadine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.00473	CcSEcCtD
Fexofenadine—Viral infection—Prednisolone—chronic obstructive pulmonary disease	0.00106	0.00468	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00455	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00455	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00448	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00445	CcSEcCtD
Fexofenadine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000999	0.0044	CcSEcCtD
Fexofenadine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000989	0.00435	CcSEcCtD
Fexofenadine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000988	0.00435	CcSEcCtD
Fexofenadine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000984	0.00433	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000975	0.00429	CcSEcCtD
Fexofenadine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000971	0.00427	CcSEcCtD
Fexofenadine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000936	0.00412	CcSEcCtD
Fexofenadine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000935	0.00412	CcSEcCtD
Fexofenadine—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00093	0.00409	CcSEcCtD
Fexofenadine—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00093	0.00409	CcSEcCtD
Fexofenadine—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000928	0.00409	CcSEcCtD
Fexofenadine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000918	0.00404	CcSEcCtD
Fexofenadine—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000916	0.00403	CcSEcCtD
Fexofenadine—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000911	0.00401	CcSEcCtD
Fexofenadine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000904	0.00398	CcSEcCtD
Fexofenadine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000899	0.00396	CcSEcCtD
Fexofenadine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000894	0.00393	CcSEcCtD
Fexofenadine—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000883	0.00389	CcSEcCtD
Fexofenadine—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000878	0.00386	CcSEcCtD
Fexofenadine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000877	0.00386	CcSEcCtD
Fexofenadine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000852	0.00375	CcSEcCtD
Fexofenadine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000848	0.00373	CcSEcCtD
Fexofenadine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000837	0.00369	CcSEcCtD
Fexofenadine—Fluspirilene—SLC6A4—chronic obstructive pulmonary disease	0.000835	0.292	CrCbGaD
Fexofenadine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00083	0.00366	CcSEcCtD
Fexofenadine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000825	0.00363	CcSEcCtD
Fexofenadine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000824	0.00363	CcSEcCtD
Fexofenadine—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000817	0.0036	CcSEcCtD
Fexofenadine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000811	0.00357	CcSEcCtD
Fexofenadine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000799	0.00352	CcSEcCtD
Fexofenadine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000792	0.00349	CcSEcCtD
Fexofenadine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000785	0.00346	CcSEcCtD
Fexofenadine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000784	0.00345	CcSEcCtD
Fexofenadine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00078	0.00343	CcSEcCtD
Fexofenadine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00078	0.00343	CcSEcCtD
Fexofenadine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000778	0.00342	CcSEcCtD
Fexofenadine—Viral infection—Prednisone—chronic obstructive pulmonary disease	0.000772	0.0034	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000768	0.00338	CcSEcCtD
Fexofenadine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000764	0.00336	CcSEcCtD
Fexofenadine—Tension—Formoterol—chronic obstructive pulmonary disease	0.00076	0.00335	CcSEcCtD
Fexofenadine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00076	0.00335	CcSEcCtD
Fexofenadine—Injury—Prednisolone—chronic obstructive pulmonary disease	0.000758	0.00334	CcSEcCtD
Fexofenadine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000752	0.00331	CcSEcCtD
Fexofenadine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000752	0.00331	CcSEcCtD
Fexofenadine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000751	0.00331	CcSEcCtD
Fexofenadine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000749	0.0033	CcSEcCtD
Fexofenadine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000749	0.0033	CcSEcCtD
Fexofenadine—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000741	0.00326	CcSEcCtD
Fexofenadine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00074	0.00326	CcSEcCtD
Fexofenadine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000731	0.00322	CcSEcCtD
Fexofenadine—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000721	0.00317	CcSEcCtD
Fexofenadine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000718	0.00316	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000714	0.00314	CcSEcCtD
Fexofenadine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000712	0.00313	CcSEcCtD
Fexofenadine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000712	0.00313	CcSEcCtD
Fexofenadine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00071	0.00313	CcSEcCtD
Fexofenadine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000708	0.00312	CcSEcCtD
Fexofenadine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000708	0.00312	CcSEcCtD
Fexofenadine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000708	0.00312	CcSEcCtD
Fexofenadine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000707	0.00311	CcSEcCtD
Fexofenadine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000697	0.00307	CcSEcCtD
Fexofenadine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000693	0.00305	CcSEcCtD
Fexofenadine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000689	0.00303	CcSEcCtD
Fexofenadine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000684	0.00301	CcSEcCtD
Fexofenadine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000684	0.00301	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000679	0.00299	CcSEcCtD
Fexofenadine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000676	0.00297	CcSEcCtD
Fexofenadine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000676	0.00297	CcSEcCtD
Fexofenadine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000672	0.00296	CcSEcCtD
Fexofenadine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00067	0.00295	CcSEcCtD
Fexofenadine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000668	0.00294	CcSEcCtD
Fexofenadine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000662	0.00291	CcSEcCtD
Fexofenadine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00066	0.0029	CcSEcCtD
Fexofenadine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000659	0.0029	CcSEcCtD
Fexofenadine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000659	0.0029	CcSEcCtD
Fexofenadine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000657	0.00289	CcSEcCtD
Fexofenadine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000657	0.00289	CcSEcCtD
Fexofenadine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000646	0.00284	CcSEcCtD
Fexofenadine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000646	0.00284	CcSEcCtD
Fexofenadine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000645	0.00284	CcSEcCtD
Fexofenadine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000645	0.00284	CcSEcCtD
Fexofenadine—Fluspirilene—HTR2A—chronic obstructive pulmonary disease	0.000642	0.224	CrCbGaD
Fexofenadine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00064	0.00282	CcSEcCtD
Fexofenadine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000638	0.00281	CcSEcCtD
Fexofenadine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000632	0.00278	CcSEcCtD
Fexofenadine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000632	0.00278	CcSEcCtD
Fexofenadine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000628	0.00276	CcSEcCtD
Fexofenadine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000628	0.00276	CcSEcCtD
Fexofenadine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000623	0.00274	CcSEcCtD
Fexofenadine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000622	0.00274	CcSEcCtD
Fexofenadine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000619	0.00273	CcSEcCtD
Fexofenadine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000619	0.00273	CcSEcCtD
Fexofenadine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000617	0.00272	CcSEcCtD
Fexofenadine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000617	0.00272	CcSEcCtD
Fexofenadine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000615	0.00271	CcSEcCtD
Fexofenadine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000612	0.00269	CcSEcCtD
Fexofenadine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.00268	CcSEcCtD
Fexofenadine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000597	0.00263	CcSEcCtD
Fexofenadine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000593	0.00261	CcSEcCtD
Fexofenadine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000588	0.00259	CcSEcCtD
Fexofenadine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000582	0.00256	CcSEcCtD
Fexofenadine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000577	0.00254	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000576	0.00253	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000576	0.00253	CcSEcCtD
Fexofenadine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000572	0.00252	CcSEcCtD
Fexofenadine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000572	0.00252	CcSEcCtD
Fexofenadine—Pimozide—CYP1A2—chronic obstructive pulmonary disease	0.000568	0.199	CrCbGaD
Fexofenadine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000568	0.0025	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000564	0.00248	CcSEcCtD
Fexofenadine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000564	0.00248	CcSEcCtD
Fexofenadine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000564	0.00248	CcSEcCtD
Fexofenadine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000562	0.00247	CcSEcCtD
Fexofenadine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000562	0.00247	CcSEcCtD
Fexofenadine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00056	0.00246	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000558	0.00246	CcSEcCtD
Fexofenadine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000556	0.00245	CcSEcCtD
Fexofenadine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000556	0.00245	CcSEcCtD
Fexofenadine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000554	0.00244	CcSEcCtD
Fexofenadine—Injury—Prednisone—chronic obstructive pulmonary disease	0.000551	0.00242	CcSEcCtD
Fexofenadine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00055	0.00242	CcSEcCtD
Fexofenadine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000549	0.00242	CcSEcCtD
Fexofenadine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000545	0.0024	CcSEcCtD
Fexofenadine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000545	0.0024	CcSEcCtD
Fexofenadine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000545	0.0024	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000544	0.00239	CcSEcCtD
Fexofenadine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000541	0.00238	CcSEcCtD
Fexofenadine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000541	0.00238	CcSEcCtD
Fexofenadine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00054	0.00238	CcSEcCtD
Fexofenadine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000539	0.00237	CcSEcCtD
Fexofenadine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000534	0.00235	CcSEcCtD
Fexofenadine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000532	0.00234	CcSEcCtD
Fexofenadine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000531	0.00234	CcSEcCtD
Fexofenadine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000529	0.00233	CcSEcCtD
Fexofenadine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000528	0.00232	CcSEcCtD
Fexofenadine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000525	0.00231	CcSEcCtD
Fexofenadine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000524	0.0023	CcSEcCtD
Fexofenadine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000523	0.0023	CcSEcCtD
Fexofenadine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00052	0.00229	CcSEcCtD
Fexofenadine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000518	0.00228	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000517	0.00228	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000517	0.00228	CcSEcCtD
Fexofenadine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000515	0.00226	CcSEcCtD
Fexofenadine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00051	0.00225	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000506	0.00223	CcSEcCtD
Fexofenadine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000502	0.00221	CcSEcCtD
Fexofenadine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000502	0.00221	CcSEcCtD
Fexofenadine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.0005	0.0022	CcSEcCtD
Fexofenadine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.0005	0.0022	CcSEcCtD
Fexofenadine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.0005	0.0022	CcSEcCtD
Fexofenadine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.0005	0.0022	CcSEcCtD
Fexofenadine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000498	0.00219	CcSEcCtD
Fexofenadine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000494	0.00218	CcSEcCtD
Fexofenadine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000494	0.00217	CcSEcCtD
Fexofenadine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000493	0.00217	CcSEcCtD
Fexofenadine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000493	0.00217	CcSEcCtD
Fexofenadine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000492	0.00216	CcSEcCtD
Fexofenadine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000491	0.00216	CcSEcCtD
Fexofenadine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000489	0.00215	CcSEcCtD
Fexofenadine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000489	0.00215	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000488	0.00215	CcSEcCtD
Fexofenadine—Pimozide—HTR2A—chronic obstructive pulmonary disease	0.00048	0.168	CrCbGaD
Fexofenadine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.00209	CcSEcCtD
Fexofenadine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.00208	CcSEcCtD
Fexofenadine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.00208	CcSEcCtD
Fexofenadine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000466	0.00205	CcSEcCtD
Fexofenadine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000466	0.00205	CcSEcCtD
Fexofenadine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000465	0.00205	CcSEcCtD
Fexofenadine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000456	0.00201	CcSEcCtD
Fexofenadine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000453	0.002	CcSEcCtD
Fexofenadine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000453	0.002	CcSEcCtD
Fexofenadine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000447	0.00197	CcSEcCtD
Fexofenadine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000447	0.00197	CcSEcCtD
Fexofenadine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000444	0.00196	CcSEcCtD
Fexofenadine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00044	0.00194	CcSEcCtD
Fexofenadine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000438	0.00193	CcSEcCtD
Fexofenadine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000432	0.0019	CcSEcCtD
Fexofenadine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.0019	CcSEcCtD
Fexofenadine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000428	0.00188	CcSEcCtD
Fexofenadine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000424	0.00186	CcSEcCtD
Fexofenadine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000422	0.00186	CcSEcCtD
Fexofenadine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000418	0.00184	CcSEcCtD
Fexofenadine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000418	0.00184	CcSEcCtD
Fexofenadine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000409	0.0018	CcSEcCtD
Fexofenadine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.0018	CcSEcCtD
Fexofenadine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000402	0.00177	CcSEcCtD
Fexofenadine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.00177	CcSEcCtD
Fexofenadine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000399	0.00175	CcSEcCtD
Fexofenadine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000399	0.00175	CcSEcCtD
Fexofenadine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000398	0.00175	CcSEcCtD
Fexofenadine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.00175	CcSEcCtD
Fexofenadine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.00174	CcSEcCtD
Fexofenadine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000396	0.00174	CcSEcCtD
Fexofenadine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000395	0.00174	CcSEcCtD
Fexofenadine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00174	CcSEcCtD
Fexofenadine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000394	0.00173	CcSEcCtD
Fexofenadine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00039	0.00172	CcSEcCtD
Fexofenadine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00039	0.00172	CcSEcCtD
Fexofenadine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000388	0.00171	CcSEcCtD
Fexofenadine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000383	0.00169	CcSEcCtD
Fexofenadine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.00167	CcSEcCtD
Fexofenadine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00166	CcSEcCtD
Fexofenadine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00165	CcSEcCtD
Fexofenadine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00165	CcSEcCtD
Fexofenadine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00165	CcSEcCtD
Fexofenadine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.00165	CcSEcCtD
Fexofenadine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000368	0.00162	CcSEcCtD
Fexofenadine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00156	CcSEcCtD
Fexofenadine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000342	0.00151	CcSEcCtD
Fexofenadine—Methadone—CYP1A2—chronic obstructive pulmonary disease	0.000338	0.118	CrCbGaD
Fexofenadine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.00147	CcSEcCtD
Fexofenadine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000325	0.00143	CcSEcCtD
Fexofenadine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00031	0.00136	CcSEcCtD
Fexofenadine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000293	0.00129	CcSEcCtD
Fexofenadine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000287	0.00126	CcSEcCtD
Fexofenadine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00028	0.00123	CcSEcCtD
Fexofenadine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000278	0.00123	CcSEcCtD
Fexofenadine—SLCO2B1—Transport of organic anions—ALB—chronic obstructive pulmonary disease	0.000276	0.0531	CbGpPWpGaD
Fexofenadine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000272	0.0012	CcSEcCtD
Fexofenadine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000259	0.00114	CcSEcCtD
Fexofenadine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000252	0.00111	CcSEcCtD
Fexofenadine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00109	CcSEcCtD
Fexofenadine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000247	0.00109	CcSEcCtD
Fexofenadine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00107	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000998	CcSEcCtD
Fexofenadine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.000996	CcSEcCtD
Fexofenadine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000225	0.00099	CcSEcCtD
Fexofenadine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000964	CcSEcCtD
Fexofenadine—SLCO1B3—Transport of organic anions—ALB—chronic obstructive pulmonary disease	0.000216	0.0415	CbGpPWpGaD
Fexofenadine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.00095	CcSEcCtD
Fexofenadine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.000949	CcSEcCtD
Fexofenadine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000944	CcSEcCtD
Fexofenadine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.000944	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000895	CcSEcCtD
Fexofenadine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.000895	CcSEcCtD
Fexofenadine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00087	CcSEcCtD
Fexofenadine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000866	CcSEcCtD
Fexofenadine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000866	CcSEcCtD
Fexofenadine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000807	CcSEcCtD
Fexofenadine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000786	CcSEcCtD
Fexofenadine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000775	CcSEcCtD
Fexofenadine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000749	CcSEcCtD
Fexofenadine—SLCO1A2—Transport of organic anions—ALB—chronic obstructive pulmonary disease	0.00017	0.0326	CbGpPWpGaD
Fexofenadine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000724	CcSEcCtD
Fexofenadine—SLCO1B3—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.00016	0.0307	CbGpPWpGaD
Fexofenadine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000696	CcSEcCtD
Fexofenadine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00069	CcSEcCtD
Fexofenadine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00069	CcSEcCtD
Fexofenadine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000686	CcSEcCtD
Fexofenadine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00065	CcSEcCtD
Fexofenadine—SLCO1B1—Transport of organic anions—ALB—chronic obstructive pulmonary disease	0.000145	0.0279	CbGpPWpGaD
Fexofenadine—SLCO1A2—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.000126	0.0242	CbGpPWpGaD
Fexofenadine—SLCO1B1—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.000107	0.0207	CbGpPWpGaD
Fexofenadine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000103	0.0197	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.000103	0.0197	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	9.5e-05	0.0183	CbGpPWpGaD
Fexofenadine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	8.59e-05	0.0165	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	8.47e-05	0.0163	CbGpPWpGaD
Fexofenadine—HRH1—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	8.4e-05	0.0161	CbGpPWpGaD
Fexofenadine—SLCO1B3—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	8.36e-05	0.0161	CbGpPWpGaD
Fexofenadine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	8.26e-05	0.0159	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	8.01e-05	0.0154	CbGpPWpGaD
Fexofenadine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	7.46e-05	0.0143	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	7.42e-05	0.0143	CbGpPWpGaD
Fexofenadine—HRH1—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	7.06e-05	0.0136	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	6.61e-05	0.0127	CbGpPWpGaD
Fexofenadine—SLCO1A2—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	6.57e-05	0.0126	CbGpPWpGaD
Fexofenadine—HRH1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	6.57e-05	0.0126	CbGpPWpGaD
Fexofenadine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	6.38e-05	0.0123	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	6.29e-05	0.0121	CbGpPWpGaD
Fexofenadine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	6.24e-05	0.012	CbGpPWpGaD
Fexofenadine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	6e-05	0.0115	CbGpPWpGaD
Fexofenadine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	5.96e-05	0.0115	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	5.83e-05	0.0112	CbGpPWpGaD
Fexofenadine—SLCO1B1—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	5.62e-05	0.0108	CbGpPWpGaD
Fexofenadine—HRH1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	5.52e-05	0.0106	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	5.38e-05	0.0103	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	5.19e-05	0.00998	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	4.98e-05	0.00958	CbGpPWpGaD
Fexofenadine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	4.95e-05	0.00951	CbGpPWpGaD
Fexofenadine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	4.64e-05	0.00891	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	4.44e-05	0.00854	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.1e-05	0.00787	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	3.72e-05	0.00715	CbGpPWpGaD
Fexofenadine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	3.65e-05	0.00701	CbGpPWpGaD
Fexofenadine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	3.57e-05	0.00685	CbGpPWpGaD
Fexofenadine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	3.52e-05	0.00676	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	3.42e-05	0.00658	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	3.39e-05	0.00652	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.22e-05	0.00619	CbGpPWpGaD
Fexofenadine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	2.89e-05	0.00556	CbGpPWpGaD
Fexofenadine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	2.88e-05	0.00554	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—APIP—chronic obstructive pulmonary disease	2.83e-05	0.00544	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.75e-05	0.00529	CbGpPWpGaD
Fexofenadine—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	2.72e-05	0.00522	CbGpPWpGaD
Fexofenadine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	2.59e-05	0.00498	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	2.58e-05	0.00497	CbGpPWpGaD
Fexofenadine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	2.56e-05	0.00491	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	2.49e-05	0.00479	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	2.33e-05	0.00447	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.23e-05	0.00428	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	2.22e-05	0.00427	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	2.21e-05	0.00426	CbGpPWpGaD
Fexofenadine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	2.21e-05	0.00425	CbGpPWpGaD
Fexofenadine—SLCO2B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.2e-05	0.00423	CbGpPWpGaD
Fexofenadine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.1e-05	0.00404	CbGpPWpGaD
Fexofenadine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	2.06e-05	0.00396	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.02e-05	0.00388	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	1.9e-05	0.00366	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.88e-05	0.00361	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	1.87e-05	0.0036	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.86e-05	0.00358	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.86e-05	0.00358	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.85e-05	0.00355	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.83e-05	0.00351	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GC—chronic obstructive pulmonary disease	1.82e-05	0.00351	CbGpPWpGaD
Fexofenadine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	1.74e-05	0.00333	CbGpPWpGaD
Fexofenadine—SLCO1B3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	1.72e-05	0.0033	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.7e-05	0.00326	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	1.69e-05	0.00324	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	1.68e-05	0.00322	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	1.64e-05	0.00315	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	1.62e-05	0.00312	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.59e-05	0.00305	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.54e-05	0.00295	CbGpPWpGaD
Fexofenadine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.51e-05	0.00291	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.47e-05	0.00283	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	1.47e-05	0.00282	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.46e-05	0.00281	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.46e-05	0.0028	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.43e-05	0.00276	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	1.39e-05	0.00267	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.38e-05	0.00265	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.36e-05	0.00261	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.35e-05	0.0026	CbGpPWpGaD
Fexofenadine—SLCO1A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	1.35e-05	0.0026	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.33e-05	0.00256	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.28e-05	0.00246	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	1.27e-05	0.00245	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.27e-05	0.00244	CbGpPWpGaD
Fexofenadine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.26e-05	0.00243	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.26e-05	0.00242	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.25e-05	0.0024	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.24e-05	0.00239	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	1.23e-05	0.00236	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	1.22e-05	0.00235	CbGpPWpGaD
Fexofenadine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	1.19e-05	0.00229	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.18e-05	0.00227	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.18e-05	0.00226	CbGpPWpGaD
Fexofenadine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.16e-05	0.00223	CbGpPWpGaD
Fexofenadine—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	1.16e-05	0.00222	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.14e-05	0.0022	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.14e-05	0.00219	CbGpPWpGaD
Fexofenadine—SLCO2B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.12e-05	0.00215	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.12e-05	0.00214	CbGpPWpGaD
Fexofenadine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.00211	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.09e-05	0.00209	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.07e-05	0.00206	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.06e-05	0.00204	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.06e-05	0.00203	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	1.03e-05	0.00199	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.97e-06	0.00192	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GCLC—chronic obstructive pulmonary disease	9.86e-06	0.00189	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.78e-06	0.00188	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	9.53e-06	0.00183	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	9.53e-06	0.00183	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	9.49e-06	0.00182	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	9.45e-06	0.00182	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.19e-06	0.00177	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.08e-06	0.00175	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CTGF—chronic obstructive pulmonary disease	8.99e-06	0.00173	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	8.98e-06	0.00172	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	8.86e-06	0.0017	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.74e-06	0.00168	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	8.65e-06	0.00166	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.37e-06	0.00161	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.29e-06	0.00159	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.27e-06	0.00159	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.83e-06	0.00151	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.74e-06	0.00149	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.22e-06	0.00139	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.07e-06	0.00136	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.91e-06	0.00133	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.86e-06	0.00132	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.82e-06	0.00131	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.71e-06	0.00129	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.7e-06	0.00129	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	6.62e-06	0.00127	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.62e-06	0.00127	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.51e-06	0.00125	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.35e-06	0.00122	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.34e-06	0.00122	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.31e-06	0.00121	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.17e-06	0.00119	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	6.14e-06	0.00118	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.04e-06	0.00116	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.02e-06	0.00116	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.98e-06	0.00115	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.95e-06	0.00114	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.87e-06	0.00113	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	5.78e-06	0.00111	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.71e-06	0.0011	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.57e-06	0.00107	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.43e-06	0.00104	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.43e-06	0.00104	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.38e-06	0.00103	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.35e-06	0.00103	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.34e-06	0.00103	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.11e-06	0.000982	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.11e-06	0.000982	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.1e-06	0.00098	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	5.09e-06	0.000978	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.99e-06	0.000959	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.89e-06	0.000941	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.85e-06	0.000932	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.73e-06	0.000909	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.68e-06	0.0009	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.67e-06	0.000898	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.64e-06	0.000892	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.59e-06	0.000882	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.58e-06	0.00088	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.37e-06	0.00084	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.27e-06	0.00082	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.24e-06	0.000816	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ALB—chronic obstructive pulmonary disease	4.09e-06	0.000786	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.04e-06	0.000777	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.91e-06	0.000752	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.85e-06	0.000741	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.74e-06	0.000718	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.48e-06	0.000668	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.35e-06	0.000644	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.31e-06	0.000637	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.22e-06	0.000618	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.21e-06	0.000616	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.16e-06	0.000607	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	3.12e-06	0.0006	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.08e-06	0.000591	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.02e-06	0.000581	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.94e-06	0.000565	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.89e-06	0.000555	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.87e-06	0.000551	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.85e-06	0.000548	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.79e-06	0.000536	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	2.75e-06	0.000528	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.63e-06	0.000505	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.63e-06	0.000505	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.62e-06	0.000504	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.6e-06	0.000501	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.51e-06	0.000482	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.33e-06	0.000448	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.32e-06	0.000447	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.29e-06	0.000441	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.19e-06	0.000421	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.16e-06	0.000415	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.14e-06	0.00041	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.02e-06	0.000389	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.01e-06	0.000387	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.92e-06	0.000368	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.91e-06	0.000367	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.83e-06	0.000351	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.75e-06	0.000336	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.55e-06	0.000298	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.47e-06	0.000283	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.4e-06	0.000269	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.38e-06	0.000265	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.32e-06	0.000253	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.3e-06	0.000249	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.26e-06	0.000242	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.24e-06	0.000238	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.15e-06	0.000222	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.13e-06	0.000218	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.51e-07	0.000183	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.7e-07	0.000167	CbGpPWpGaD
